LicoarylcoumarinCAS# 125709-31-1 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 125709-31-1 | SDF | Download SDF |
PubChem ID | 10090416 | Appearance | Powder |
Formula | C21H20O6 | M.Wt | 368.4 |
Type of Compound | Coumarins | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 3-(2,4-dihydroxyphenyl)-7-hydroxy-5-methoxy-8-(2-methylbut-3-en-2-yl)chromen-2-one | ||
SMILES | CC(C)(C=C)C1=C(C=C(C2=C1OC(=O)C(=C2)C3=C(C=C(C=C3)O)O)OC)O | ||
Standard InChIKey | LCRIQVFKVCYUAO-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C21H20O6/c1-5-21(2,3)18-16(24)10-17(26-4)14-9-13(20(25)27-19(14)18)12-7-6-11(22)8-15(12)23/h5-10,22-24H,1H2,2-4H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Licoarylcoumarin has antibacterial effects on the VRE strains. 2. Licoarylcoumarin is a strong inhibitor of adenosine 3',5'-cyclic monophosphate (cAMP) phosphodiesterase. 3. Licoarylcoumarin has anti-HIV activity, and it has inhibitory effects on xanthine oxidase. |
Targets | cAMP | HIV | Antifection |
Licoarylcoumarin Dilution Calculator
Licoarylcoumarin Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.7144 mL | 13.5722 mL | 27.1444 mL | 54.2888 mL | 67.861 mL |
5 mM | 0.5429 mL | 2.7144 mL | 5.4289 mL | 10.8578 mL | 13.5722 mL |
10 mM | 0.2714 mL | 1.3572 mL | 2.7144 mL | 5.4289 mL | 6.7861 mL |
50 mM | 0.0543 mL | 0.2714 mL | 0.5429 mL | 1.0858 mL | 1.3572 mL |
100 mM | 0.0271 mL | 0.1357 mL | 0.2714 mL | 0.5429 mL | 0.6786 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Protodeltonin
Catalog No.:BCN8611
CAS No.:94992-08-2
- Gambogellic acid
Catalog No.:BCN8609
CAS No.:173867-04-4
- Cnidicin
Catalog No.:BCN8608
CAS No.:14348-21-1
- Lucidenic acid B
Catalog No.:BCN8607
CAS No.:95311-95-8
- Toringin
Catalog No.:BCN8606
CAS No.:1329-10-8
- Saikosaponin I
Catalog No.:BCN8605
CAS No.:103629-71-6
- Uvarigranol C
Catalog No.:BCN8604
CAS No.:172104-04-0
- 9-Methymyrrhone
Catalog No.:BCN8603
CAS No.:1809980-22-0
- Asperosaponin IV
Catalog No.:BCN8602
CAS No.:126778-93-6
- Rubipodanone A
Catalog No.:BCN8601
CAS No.:2170211-22-8
- Astraganoside
Catalog No.:BCN8600
CAS No.:1011711-05-9
- Isoastragaloside IV
Catalog No.:BCN8599
CAS No.:136033-55-1
- Pratensein 7-O-glucopyranoside
Catalog No.:BCN8613
CAS No.:36191-03-4
- Plantainoside D
Catalog No.:BCN8614
CAS No.:147331-98-4
- Suspenoidside B
Catalog No.:BCN8615
CAS No.:2161432-08-0
- 7beta-Hydroxybufalin
Catalog No.:BCN8616
CAS No.:20143-97-9
- 6'-O-Cinnamoylharpagide
Catalog No.:BCN8617
CAS No.:1245572-24-0
- 3,4,4a,9,10,10a-heexahydro-8-hydroxy-1-(hydroxymethyl)-1,4a-dimethyl-7-(1-methylethyl)-phenanthrene-2(1H)-one
Catalog No.:BCN8618
CAS No.:262599-12-2
- Sargentol
Catalog No.:BCN8619
CAS No.:623928-18-7
- Onjisaponin Z
Catalog No.:BCN8620
CAS No.:1078708-72-1
- Periplocoside M
Catalog No.:BCN8621
CAS No.:116782-73-1
- Sibirioside A
Catalog No.:BCN8622
CAS No.:173046-19-0
- Laetanine
Catalog No.:BCN8623
CAS No.:72361-67-2
- Seconeokadsuranic acid A
Catalog No.:BCN8624
CAS No.:124817-74-9
Inhibition of adenosine 3',5'-cyclic monophosphate phosphodiesterase by flavonoids from licorice roots and 4-arylcoumarins.[Pubmed:1654220]
Chem Pharm Bull (Tokyo). 1991 Apr;39(4):930-3.
Isoliquiritigenin, glabridin, Licoarylcoumarin and licoricidin were identified as strong inhibitors of adenosine 3',5'-cyclic monophosphate (cAMP) phosphodiesterase in waste materials which were obtained during the industrial extraction of glycyrrhizin from licorice roots. The structure-activity relationships of 12 flavonoids from licorice roots and 34 4-arylcoumarins were studied. In 4-arylcoumarins, 5,7-dihydroxy derivatives were generally highly inhibitory towards cAMP phosphodiesterase.
Phenolic constituents of licorice. II. Structures of licopyranocoumarin, licoarylcoumarin and glisoflavone, and inhibitory effects of licorice phenolics on xanthine oxidase.[Pubmed:2632045]
Chem Pharm Bull (Tokyo). 1989 Nov;37(11):3005-9.
An anti-HIV (human immunodeficiency virus) phenolic constituent, licopyranocoumarin (4), and two other new phenolics named Licoarylcoumarin (5) and glisoflavone (6) were isolated from Si-pei licorice (a commercial licorice; root and stolon of Glycyrrhiza sp. from the north-western region of China) using droplet countercurrent chromatography and centrifugal partition chromatography, and their structures were assigned based on chemical and spectroscopic data. Kaempferol 3-O-methyl ether (7) and licocoumarone (8) were also isolated from the licorice. The inhibitory effects of ten licorice phenolics on xanthine oxidase were examined. Licochalcone B (1), glycyrrhisoflavone (2), 8 and licochalcone A (19) showed 50% inhibition at the concentration of 1.3-5.6 x 10(-5) M.
Structures of two new flavonoids and effects of licorice phenolics on vancomycin-resistant Enterococcus species.[Pubmed:24686577]
Molecules. 2014 Mar 28;19(4):3883-97.
Since our previous study revealed that several licorice phenolics have antibacterial effects on methicillin-resistant Staphylococcus aureus (MRSA), and suppressive effects on the oxacillin resistance of MRSA, we further investigated effectiveness of licorice constituents on vancomycin-resistant Enterococcus (VRE) bacteria, and purified 32 phenolic compounds. Two flavonoids among them were characterized structurally, and identified their structures as demethylglycyrol (31) and 5,7-di-O-methylluteone (32), respectively. Examination of antibacterial effects of licorice phenolics showed that 3-arylcoumarins such as Licoarylcoumarin (9) and glycycoumarin (26), and 2-arylcoumarones such as gancaonin I (17), have moderate to potent antibacterial effects on the VRE strains used in this study.